Paper2867985
Bethanechol versus antiacids in the treatment of gastroesophageal reflux.
Levi P and 8 others. Helv Paediatr Acta, 1985. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Bethanechol versus antiacids in the treatment of gastroesophageal reflux. Papers, record 2867985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2867985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aluminum Hydroxide | Major topic |
| Antacids | Major topic |
| Bethanechol Compounds | Major topic |
| Gastroesophageal Reflux | Major topic |
| Magnesium | Major topic |
| Magnesium Hydroxide | Major topic |
| Bethanechol | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Drug Combinations | |
| Gastric Acidity Determination | |
| Humans | |
| Infant | |
| Random Allocation |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35716649 | Neonatal gastroesophageal reflux. | Early Hum Dev | 2022 | https://conductscience.org/library/papers/35716649 | PubMed |
| 30899687 | Diagnosis and Management of Gastroesophageal Reflux Disease in Infants and Children: from Guidelines to Clinical Practice. | Pediatr Gastroenterol Hepatol Nutr | 2019 | https://conductscience.org/library/papers/30899687 | PubMed |
| 29470322 | Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. | J Pediatr Gastroenterol Nutr | 2018 | https://conductscience.org/library/papers/29470322 | PubMed |
| 23322552 | Gastroesophageal reflux disease in neonates and infants : when and how to treat. | Paediatr Drugs | 2013 | https://conductscience.org/library/papers/23322552 | PubMed |
| 19445547 | Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. | Paediatr Drugs | 2009 | https://conductscience.org/library/papers/19445547 | PubMed |
| 12269842 | Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/12269842 | PubMed |
| 3300570 | Cisapride for gastro-oesophageal reflux and peptic oesophagitis. | Arch Dis Child | 1987 | https://conductscience.org/library/papers/3300570 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2867985
GET https://conductscience.org/api/papers/v1/2867985/authors